Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208694

ZERVIATE (CETIRIZINE HYDROCHLORIDE)
EQ 0.24% BASE Marketing Status: Prescription

Active Ingredient: CETIRIZINE HYDROCHLORIDE
Proprietary Name: ZERVIATE
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: EQ 0.24% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N208694
Product Number: 001
Approval Date: May 30, 2017
Applicant Holder Full Name: EYEVANCE PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English